~~<i id='6BAD2F6DCB'><strike id='6BAD2F6DCB'><tt id='6BAD2F6DCB'><pre id='6BAD2F6DCB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

focus

author：explore 2025-10-01 21:37:00 - browse：8638

LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met.

AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Ebola public health emergency is over, WHO declares

entertainment

hotspot

leisure time

Wikipedia

entertainment

Wikipedia

AdobePeopleinRepublican-votingstatesweremorelikelytoreportadverseeventsafterreceivingaCovid-19vaccin

WSS

Stanford updates investigation of president’s past research

TikTok cracks down on users posting about weight loss drugs

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Celebrate National Dole Whip Day for 3 days this week at Disney

Medicare Advantage 2025 payments will dip, Biden administration says

Young boy dies in trial for Pfizer Duchenne gene therapy

explore

focus

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Young boy dies in trial for Pfizer Duchenne gene therapy

23andMe had bad news about my health. I wish a person had delivered it

Stanford updates investigation of president’s past research

Malaria cases in Florida and Texas: Here’s what you need to know

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Supreme Court strikes down use of affirmative action

Republican states more likely to report Covid vaccine side effects

How one medical school became remarkably diverse

Resistance to cancer drugs: A new genetic explanation

hotspot

Researchers separate signal from noise in heart wearable data

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Man who had jail sentence commuted by Trump arrested again

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

India sets sights on home

leisure time

Wikipedia

entertainment

Wikipedia